286.01 USD
▼-6.81-2.33%
盘后 285.95 -0.02%
2026-11-18
市值
$501.19B
市盈率
48.82
EPS
5.81
股息率
2.57%
52 周区间
190.75 – 302.93
成交量
4.85M
Beta
0.19
目标价
315.88
52W 低 190.7552W 高 302.93
价格走势

公司简介

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medi...

关联新闻